Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Crawford & Co Class B
CRD.B
$491M
| $8.37M | 0.01% |
829,117
+24,500
| +3% | +$230K |
|
1502
Hope Bancorp
HOPE
$1.79B
| $8.36M | 0.01% |
582,864
+102,300
| +21% | +$1.43M |
|
|
DOVA
1503
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $8.34M | 0.01% |
298,400
+144,700
| +94% | +$2.34M |
|
1504
Graco
GGG
$12.9B
| $8.33M | 0.01% |
180,900
+101,200
| +127% | +$4.78M |
|
|
PBPB
1505
DELISTED
Potbelly
PBPB
| $8.33M | 0.01% |
1,909,800
-32,395
| -2% | -$146K |
|
1506
Dime Commercial Bancshares
DCOM
$1.8B
| $8.3M | 0.01% |
280,800
+16,000
| +6% | +$455K |
|
1507
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
| $8.29M | 0.01% |
179,082
+55,682
| +45% | +$2.57M |
|
1508
DexCom
DXCM
$31.5B
| $8.27M | 0.01% |
221,600
-982,172
| -82% | -$38.2M |
|
|
KIN
1509
DELISTED
Kindred Biosciences, Inc.
KIN
| $8.26M | 0.01% |
1,205,698
+19,200
| +2% | +$141K |
|
1510
Monarch Casino & Resort
MCRI
$2.2B
| $8.25M | 0.01% |
197,803
+20,200
| +11% | +$900K |
|
|
IO
1511
DELISTED
ION Geophysical Corporation
IO
| $8.22M | 0.01% |
901,519
+172,770
| +24% | +$1.53M |
|
1512
Rapid7
RPD
$645M
| $8.21M | 0.01% |
180,896
+47,200
| +35% | +$2.65M |
|
1513
CTS Corp
CTS
$1.83B
| $8.19M | 0.01% |
253,000
-63,800
| -20% | -$1.9M |
|
1514
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $8.18M | 0.01% |
265,237
-73,863
| -22% | -$2.27M |
|
1515
Dentsply Sirona
XRAY
$2.68B
| $8.18M | 0.01% |
153,358
+131,900
| +615% | +$7.09M |
|
1516
Rogers Corp
ROG
$2.21B
| $8.18M | 0.01% |
+59,800
| New | +$8.81M |
|
1517
Vanguard Total International Bond ETF
BNDX
$81.9B
| $8.14M | 0.01% |
138,416
-37,000
| -21% | -$2.16M |
|
1518
Banc of California
BANC
$3.03B
| $8.14M | 0.01% |
575,825
+385,525
| +203% | +$5.56M |
|
1519
Gorman-Rupp
GRC
$2.14B
| $8.14M | 0.01% |
234,015
+24,000
| +11% | +$762K |
|
|
PCOM
1520
DELISTED
Points.com Inc. Common Shares
PCOM
| $8.12M | 0.01% |
740,330
-12,500
| -2% | -$145K |
|
|
HONE
1521
DELISTED
HarborOne Bancorp
HONE
| $8.12M | 0.01% |
806,276
+308,607
| +62% | +$3.19M |
|
1522
West Bancorporation
WTBA
$478M
| $8.06M | 0.01% |
370,552
+16,700
| +5% | +$354K |
|
1523
Atkore
ATKR
$2.46B
| $8.05M | 0.01% |
265,100
+191,900
| +262% | +$5.4M |
|
|
MFSF
1524
DELISTED
MutualFirst Financial Inc
MFSF
| $8.04M | 0.01% |
255,213
+10,200
| +4% | +$324K |
|
1525
MasTec
MTZ
$21.1B
| $8.04M | 0.01% |
123,800
-6,100
| -5% | -$356K |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.